Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass.

ABSTRACT:

Importance

Sleeve gastrectomy and gastric bypass are the most common bariatric surgical procedures in the world; however, their long-term medication discontinuation and comorbidity resolution remain unclear.

Objective

To compare the incidence of medication discontinuation and restart of diabetes, hypertension, and hyperlipidemia medications up to 5 years after sleeve gastrectomy or gastric bypass.

Design, setting, and participants

This comparative effectiveness research study of adult Medicare beneficiaries who underwent laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass between January 1, 2012, to December 31, 2018, and had a claim for diabetes, hypertension, or hyperlipidemia medication in the 6 months before surgery with a corresponding diagnosis used inst

SUBMITTER: Howard R 

PROVIDER: S-EPMC8756362 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature